Microsatellite instability: an update
H Yamamoto, K Imai - Archives of toxicology, 2015 - Springer
Deficient DNA mismatch repair (MMR) results in a strong mutator phenotype known as
microsatellite instability (MSI), which is a hallmark of Lynch syndrome-associated cancers …
microsatellite instability (MSI), which is a hallmark of Lynch syndrome-associated cancers …
Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics
K Imai, H Yamamoto - Carcinogenesis, 2008 - academic.oup.com
DNA mismatch repair (MMR) deficiency results in a strong mutator phenotype and high-
frequency microsatellite instability (MSI-H), which are the hallmarks of tumors arising within …
frequency microsatellite instability (MSI-H), which are the hallmarks of tumors arising within …
[HTML][HTML] Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications
AC Tsiatis, A Norris-Kirby, RG Rich, MJ Hafez… - The Journal of Molecular …, 2010 - Elsevier
Mutations in codons 12 and 13 of the KRAS oncogene are relatively common in colorectal
and lung adenocarcinomas. Recent data indicate that these mutations result in resistance to …
and lung adenocarcinomas. Recent data indicate that these mutations result in resistance to …
Association of KRAS G13D Tumor Mutations With Outcome in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy With or Without …
S Tejpar, I Celik, M Schlichting, U Sartorius… - Journal of clinical …, 2012 - ascopubs.org
Purpose We investigated in the first-line setting our previous finding that patients with
chemorefractory KRAS G13D–mutated metastatic colorectal cancer (mCRC) benefit from …
chemorefractory KRAS G13D–mutated metastatic colorectal cancer (mCRC) benefit from …
Three molecular pathways model colorectal carcinogenesis in L ynch syndrome
A Ahadova, R Gallon, J Gebert… - … journal of cancer, 2018 - Wiley Online Library
Lynch syndrome is caused by germline mutations of DNA mismatch repair (MMR) genes.
MMR deficiency has long been regarded as a secondary event in the pathogenesis of Lynch …
MMR deficiency has long been regarded as a secondary event in the pathogenesis of Lynch …
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer
WS Samowitz, H Albertsen, J Herrick, TR Levin… - Gastroenterology, 2005 - Elsevier
Background & Aims: The concept of a CpG island methylator phenotype (CIMP), especially
in microsatellite stable colon cancer, is not accepted universally. We therefore evaluated a …
in microsatellite stable colon cancer, is not accepted universally. We therefore evaluated a …
[HTML][HTML] KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients
N Knijn, LJM Mekenkamp, M Klomp… - British journal of …, 2011 - nature.com
Background: KRAS mutation is a negative predictive factor for treatment with anti-epidermal
growth factor receptor antibody in metastatic colorectal cancer (CRC). KRAS mutation …
growth factor receptor antibody in metastatic colorectal cancer (CRC). KRAS mutation …
[HTML][HTML] Biology of colorectal cancer
F Arvelo, F Sojo, C Cotte - Ecancermedicalscience, 2015 - ncbi.nlm.nih.gov
Colorectal cancer is a serious health problem, a challenge for research, and a model for
studying the molecular mechanisms involved in its development. According to its incidence …
studying the molecular mechanisms involved in its development. According to its incidence …
The prevalence of PIK3CA mutations in gastric and colon cancer
A wide variety of tumours show PIK3CA mutations leading to increased phosphatidylinositol-
3 kinase (PI3K) activity. We have determined the frequency of PIK3CA mutations in exons 9 …
3 kinase (PI3K) activity. We have determined the frequency of PIK3CA mutations in exons 9 …
Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147
WI Gonsalves, MR Mahoney, DJ Sargent… - JNCI: Journal of the …, 2014 - academic.oup.com
Abstract Background KRAS and BRAF V600E mutations are important predictive and
prognostic markers, respectively, in colon cancer, but little is known about patient and …
prognostic markers, respectively, in colon cancer, but little is known about patient and …